|Smoking duration, respiratory symptoms, and COPD in adults aged≥ 45 years with a smoking history|
Y Liu, RA Pleasants, JB Croft, AG Wheaton, K Heidari, AM Malarcher, ...
International journal of chronic obstructive pulmonary disease 10, 1409, 2015
|Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis|
RA Pleasants, TR Walker, WM Samuelson
Chest 106 (4), 1124-1128, 1994
|Chronic obstructive pulmonary disease and asthma–patient characteristics and health impairment|
RA Pleasants, JA Ohar, JB Croft, Y Liu, M Kraft, DM Mannino, JF Donohue, ...
COPD: Journal of Chronic Obstructive Pulmonary Disease 11 (3), 256-266, 2014
|Characteristics and prevalence of asthma/chronic obstructive pulmonary disease overlap in the United States|
S Kumbhare, R Pleasants, JA Ohar, C Strange
Annals of the American Thoracic Society 13 (6), 803-810, 2016
|Use of antimicrobial drugs in adults before and after removal of a restriction policy|
CJ Himmelberg, RA Pleasants, DJ Weber, JM Kessler, GP Samsa, ...
American journal of hospital pharmacy 48 (6), 1220-1227, 1991
|Defining and targeting health disparities in chronic obstructive pulmonary disease|
RA Pleasants, IL Riley, DM Mannino
International journal of chronic obstructive pulmonary disease 11, 2475, 2016
|Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease|
Y Liu, RA Pleasants, JB Croft, N Lugogo, J Ohar, K Heidari, C Strange, ...
Respiratory medicine 109 (7), 851-859, 2015
|Health-related quality of life and chronic obstructive pulmonary disease in North Carolina|
DW Brown, R Pleasants, JA Ohar, M Kraft, JF Donohue, DM Mannino, ...
North American Journal of Medical Sciences 2 (2), 60, 2010
|Pharmacokinetics of vancomycin in adult cystic fibrosis patients.|
RA Pleasants, EL Michalets, DM Williams, WM Samuelson, JR Rehm, ...
Antimicrobial agents and chemotherapy 40 (1), 186-190, 1996
|Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis|
R Balkrishnan, LM Nelsen, AS Kulkarni, RA Pleasants, JT Whitmire, ...
Journal of Asthma 42 (1), 35-40, 2005
|Reassessment of cross-reactivity of spironolactone metabolites with four digoxin immunoassays|
RA Pleasants, DM Williams, RS Porter, RH Gadsden Sr
Therapeutic drug monitoring 11 (2), 200-204, 1989
|Gender and asthma-chronic obstructive pulmonary disease overlap syndrome|
AG Wheaton, RA Pleasants, JB Croft, JA Ohar, K Heidari, DM Mannino, ...
Journal of Asthma 53 (7), 720-731, 2016
|Aerosol delivery devices for obstructive lung diseases|
RA Pleasants, DR Hess
Respiratory Care 63 (6), 708-733, 2018
|Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis|
K Chen, Q Wang, RA Pleasants, L Ge, W Liu, K Peng, S Zhai
BMC infectious diseases 17 (1), 159, 2017
|Inhaled umeclidinium in COPD patients: a review and meta-analysis|
RA Pleasants, T Wang, J Gao, H Tang, JF Donohue
Drugs 76 (3), 343-361, 2016
|Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient|
WM Samuelson, RA Pleasants, MS Whitaker
Annals of Pharmacotherapy 27 (3), 302-303, 1993
Clinical pharmacy 7, 374-9, 1988
|Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.|
RA Pleasants, RH Gadsden Sr, JP McCormack, K Piveral, WT Sawyer
Clinical pharmacy 5 (10), 810, 1986
|Clinical features and treatment of pediatric patients with drug-induced anaphylaxis: a study based on pharmacovigilance data|
Y Xing, H Zhang, S Sun, X Ma, RA Pleasants, H Tang, H Zheng, S Zhai, ...
European journal of pediatrics 177 (1), 145-154, 2018
|Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion|
RA Pleasants, LM Vaughan, DM Williams, JL Fox
Annals of Pharmacotherapy 26 (10), 1221-1226, 1992